Systemic Anti-Inflammatory Effects Patients with chronic inflammation, autoimmune conditions, or systemic pain syndromes have shown interest in the potential anti-inflammatory properties of both peptides Clinical Perspective: While patient motivations are valid, it is essential that expectations are calibrated to current evidence
Long-Term Safety Is Not Yet Fully Known Animal studies have shown favorable results
Cell 179 (4), 813827 (2019)
Each compound has been examined independently in published preclinical literature
Because peptides mimic natural signals, they are thought to have fewer side effects than drugs
Researchers and purchasing institutions are responsible for ensuring that all handling, storage, and experimental use of this compound complies with applicable federal, state, and institutional regulations governing laboratory research materials.